• UCLA Health
  • myUCLAhealth
  • School of Medicine
Eye Care

Stein Eye Institute | Doheny Eye Centers

Eye Care
  • About Us
    • Message from the Chairman
    • Academic Mission
    • UCLA Stein Eye Institute
    • About Stein and Doheny Affiliation
    • Annual Report
    • Clinical Update
    • News
    • Executive Committee
    • Academic Divisions
    • Academic Centers
    • Philanthropy
    • Mobile Eye Clinic
    • Webinars
    • Job Postings
    • Events
    • Contact Us
  • EYE Newsletter
  • Conditions and Treatment
    • Eye Signs and Symptoms
    • Eye Conditions
    • Surgical Treatments
    • Non-Surgical Treatments
  • Eye Research
    • Clinical Trials
    • Clinical Research Center
    • Research Laboratories
    • Research to Prevent Blindness
    • SEI Seminar Series
    • Vision Research Core at UCLA
  • Our Providers
  • Training and Education
    • Educational Activities
    • Training Programs
  • Our Locations
    • UCLA Stein Eye Institute Westwood
    • UCLA Stein Eye Center Santa Monica
    • UCLA Stein Eye Center Calabasas
    • Doheny Eye Center UCLA Pasadena
    • Doheny Eye Center UCLA Arcadia
    • Doheny Eye Center UCLA Orange County
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Stein Eye Institute | Doheny Eye Centers

About Us

About Us

About Us

  • Message from the Chairman
  • Academic Mission
  • UCLA Stein Eye Institute
    • Board of Trustees
    • Jules and Doris Stein UCLA Support Group
    • Facilities
  • About Stein and Doheny Affiliation
  • Annual Report
  • Clinical Update
  • News
    • Eye Strain Tips
    • Low Vision
    • Aging Eyes
    • UV Protection
    • Anne Coleman AAO President Term 2020
    • Healthy Vision Month
    • Glaucoma Awareness Month
    • AMD-Feb-2021
    • AMD-month
    • Announcements
      • New Faculty
    • UCLA Stein Eye Institute Alumni Association News
  • Executive Committee
  • Academic Divisions
  • Academic Centers
    • Aesthetics
    • Clinical Research
    • Community Outreach and Policy - Vision Health
    • UCLA Center for Eye Epidemiology
    • UCLA Mobile Eye Clinic
    • Comprehensive Cataract
    • Diabetic Eye Disease
    • Laser Refractive Center
    • Macular Disease
    • Ocular Inflammatory Disease
    • Ophthalmic Oncology
    • Optic Neuropathy
    • Orbital Disease
    • Vision Genetics
    • Vision Rehabilitation
  • Philanthropy
  • Mobile Eye Clinic
  • Webinars
  • Job Postings
  • Events
  • Contact Us
  • Message from the Chairman
  • Academic Mission
  • UCLA Stein Eye Institute
  • About Stein and Doheny Affiliation
  • Annual Report
  • Clinical Update
  • News
  • Executive Committee
  • Academic Divisions
  • Academic Centers
  • Philanthropy
  • Mobile Eye Clinic
  • Webinars
  • Job Postings
  • Events
  • Contact Us
  • Eye Strain Tips
  • Low Vision
  • Aging Eyes
  • UV Protection
  • Anne Coleman AAO President Term 2020
  • Healthy Vision Month
  • Glaucoma Awareness Month
  • AMD-Feb-2021
  • AMD-month
  • Announcements
  • UCLA Stein Eye Institute Alumni Association News
  • New Faculty
  1. Home
  2. About Us
  3. News
  4. Announcements

Announcements

Share this

In Memoriam: Patricia E. Bath. MD

June 5, 2019

Patricia-Bath-MD-obit.jpg

Dr. Patricia Bath, the first female faculty member in ophthalmology at the David Geffen School of Medicine at UCLA, has died of complications from cancer. She was 76. Read the New York Times Obituary > 
UCLA Newsroom Press Release >


Four Stein Eye Institute physicians appointed to multiple ophthalmology industry leadership roles

Feb. 6, 2019

From the office of  
Bartly J. Mondino, M.D.
Director, UCLA Stein Eye Institute

On behalf of the UCLA Stein Eye Institute, it is with great pleasure to announce that Anne L. Coleman, M.D., Ph.D. has been nominated president-elect of the American Academy of Ophthalmology (AAO) and is set to begin her term as President in the year 2020. Dr. Coleman has also been approved for the honor of ARVO Gold Fellow for her exemplary contributions and dedication to ARVO.

It is also with great pleasure to announce that Lynn K. Gordon, M.D., Ph.D. has been appointed Chairman of the AAO Council. In this role, Dr. Gordon encourages, facilitates, and coordinates communications and strategies among the Academy, state societies, and ophthalmic organizations.

I am equally pleased to share that the Association of University Professors of Ophthalmology has now among its leadership ranks two faculty members from Stein Eye: JoAnn A. Giaconi, M.D. was appointed President of Medical Student Educators Council and Stacy L. Pineles, M.D. was appointed Member-at-Large of the Program Directors Council.

Physician profiles:

coleman-ann-md.jpg
Anne L. Coleman, MD, PhD 

Dr. Coleman holds The Fran and Ray Stark Foundation Chair in Ophthalmology, and is a Professor of Ophthalmology and Epidemiology. She is the Director of the Stein Eye Institute Centers for Community Outreach and Policy, Eye Epidemiology, and the UCLA Mobile Eye Clinic. In addition she is the Vice Chairman of Academic Affairs for the UCLA Department of Ophthalmology.

Dr. Coleman’s research is directed toward the diagnosis, treatment, and societal impact of glaucoma, cataracts, and age-related macular degeneration, including the study of lifestyle limitations imposed on patients with these kinds of eye diseases. Clinical projects include studies that analyze the prevention of visual impairment and blindness in school-age children, comparative effectiveness re­search, and glaucomatous visual field and optic nerve progression.



gordon-lynn-md.jpg

Lynn K. Gordon, MD, PhD

Dr. Gordon holds the Vernon O. Underwood Family Chair in Ophthalmology and is a Professor of Ophthalmology. She is also the Senior Associate Dean for Academic Diversity and the Chair of the College of Applied Anatomy for the David Geffen School of Medicine at UCLA.

Dr. Gordon’s laboratory is involved in two primary areas of research. One project investigates the role for epi­thelial membrane protein 2 (EMP2) in controlling ocular pathologic respons­es. Dr. Gordon and her colleagues identified that EMP2 plays an important role in an in-vitro model of pro­liferative vitreoretinopathy (PVR) and have evidence that EMP2 is highly ex­pressed in human retinal diseases. In addition, they recently identified that EMP2 controls VEGF production in epithelial cells and in specific tumors. The laboratory, in collaboration with others at UCLA, has recently devel­oped a designer antibody fragment that has demonstrated efficacy in in-vitro studies in the PVR model and in other animal models in vivo. This antibody has successfully controlled pathologic neovas­cularization in a corneal burn model, achieving proof of principle for using this antibody to control disease.

The second area of interest of Dr. Gordon’s group is the role of pro­grammed death 1 (PD-1), a molecule that is known to play an important role in immune regulation in the eye. PD-1 has a major function as a nega­tive regulator in the immune system. Although previous studies identified PD-1 expression in the lymphoid sys­tem, Dr. Gordon and her colleagues identified its expression in neuronal cells of the retina. Additionally her laboratory has identified that blockade of the PD-1 pathway may be protective in uveitis. Studies are ongoing to iden­tify the mechanisms of that protection.



giaconi-joann-md.jpg
JoAnn A. Giaconi, MD

Dr. Giaconi is the Health Sciences Associate Clinical Professor of Ophthalmology, and Chief of the Ophthalmology Section at the Greater Los Angeles VA Healthcare System. She is also the Co-Director of Medical Student Education at the David Geffen School of Medicine, UCLA.

Dr. Giaconi’s research focuses on the treatment of glaucoma. She is interested in glaucoma surgery outcomes and side effects. She is currently working on various projects in the Veteran population, including examination of the over­treatment or undertreatment of glaucoma. She is enrolling patients in two clinical studies at the Stein Eye Institute. One study is examining the effect of various glaucoma surgeries on the corneal endothelium, which is the layer of cells that keeps the cornea clear, and the other study is investigating a new surgical device.



pineles-stacy-md.jpg

Stacy L. Pineles, MD

Dr. Pineles holds the Jerome and Joan Snyder Chair in Ophthalmology and is an Associate Professor of Ophthalmology at the UCLA Stein Eye Institute.

Her research interests include evaluating the surgical outcomes of strabismus surgery and studying pe­diatric optic nerve diseases. With her dual training in pediatric ophthalmol­ogy and neuro-ophthalmology, she has a special interest in pediatric neuro-ophthalmic diseases, as well as adult patients with amblyopia and neurologic causes of strabismus.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth